Search - tctmd.com

Displaying 641 - 660 of 704

Sort: Relevancy | Date

News Daily News

Hemodiafiltration Lowers Mortality in ACS Patients With Renal, Cardiac Dysfunction

November 06, 2014

News Daily News

Registry Study: Survival Benefit for Treating CTO After Primary PCI

Todd Neale

October 10, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Daily News

Cardiac Troponin T Threshold Predicts Mortality After PCI

August 20, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Leah Lawrence

July 03, 2014

News Daily News

Study of STEMI Care in China Exposes Crucial Treatment Gaps

L.A. McKeown

June 27, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

Presentation

Prevention of CIN with N-acetylcysteine or Sodium Bicarbonate in Patients with STEMI

Presenter: Per Thayssen

April 15, 2014

News Daily News

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

Yael L. Maxwell

April 15, 2014

News Conference News ACC 2014

High-sensitivity Troponin Testing May Prevent Unnecessary Admissions for Chest Pain

L.A. McKeown

March 30, 2014

News Daily News

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Caitlin E. Cox

March 27, 2014

News Daily News

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

March 05, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Presentation

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Presenter: M. Leoncini

October 09, 2013

News Daily News

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

July 05, 2013

News Daily News

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

July 05, 2013

Advertisement

Hemodiafiltration Lowers Mortality in ACS Patients With Renal, Cardiac Dysfunction

Registry Study: Survival Benefit for Treating CTO After Primary PCI

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

Cardiac Troponin T Threshold Predicts Mortality After PCI

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Study of STEMI Care in China Exposes Crucial Treatment Gaps

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Prevention of CIN with N-acetylcysteine or Sodium Bicarbonate in Patients with STEMI

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

High-sensitivity Troponin Testing May Prevent Unnecessary Admissions for Chest Pain

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content